Genetic variants in recurrent euploid pregnancy loss
Variant / mechanism
Biallelic, hemizygous, inherited, presumed de novo or parental germline mosaic monogenic variants in early developmental genes
Summary
Genome sequencing was performed in 118 families with unexplained recurrent pregnancy loss and normal karyotype and chromosomal microarray, 95% without major fetal structural anomalies on ultrasound. A prioritization pipeline integrating model organisms, population databases, developmental pathways and fetal transcriptomes identified a pathogenic or likely pathogenic variant in 18 families (15.3%) across 17 genes: biallelic (DHCR7, PIEZO1, PIGV, PRF1, SLC12A3, SMN1), hemizygous (ALAS2, IKBKG), inherited from a parent (MYH3, TNNI3, SCN5A, FLT4), presumed de novo (EFTUD2, HNRNPK, FGFR2, KAT6A) or from parental germline mosaicism (FGFR2, PORCN). Variants of uncertain significance were found in 12 families (10.2%), and four families carried biallelic ultra-rare variants in developmental genes not yet linked to human disease. Of 28 genes with plausible variants, 13 had previously been implicated in perinatal lethality and 15 were novel candidates; variants were inherited in 80% of families.
Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.
Analysis
Recurrent euploid pregnancy loss has a measurable monogenic component, with a key point for counselling: variants are inherited in 80% of families, which makes recurrence risk quantifiable and also concerns carrier parents. Genome sequencing becomes a defensible test after a normal karyotype and microarray; the 15 candidate genes, however, must be confirmed before any diagnostic use.
Analysis by Dr Thibaut Benquey
Why this score?
Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 7/10
Keywords
Every Wednesday · Annotated selection · Free · Unsubscribe anytime